Pharma and Biotech
Competitors: | Hemogenyx Pharmaceuticals |
Executive Director: | Daniel Gooding |
Independent Non-Executive Director: | Madeleine Kennedy |
Non-Executive Chairman: | Julian Gilbert |
Non-Executive Dir: |
Address: | C/O Arch Law Limited, Huckletree Bishopsgate, 8 Bishopsgate, London, United Kingdom, EC2N 4BQ |
Phone: | +44 (0)1223 627222 |
Website: | https://nuformix.com/ |
Sector: | Pharma and Biotech(LSE) |
ISIN: | GB00BYW79Y38 |
Currency | UK Pounds |
Share Price | 0.20p |
Change Today | 0.033p |
% Change | 20.00 % |
52 Week High | 0.22 |
52 Week Low | 0.048 |
Volume | 188,215,605 |
Shares Issued | 1,669.31m |
Market Cap | £3.26m |
RiskGrade | 322 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
08:58 | 2,000,000 @ 0.14p |
08:57 | 622,111 @ 0.14p |
08:57 | 746,663 @ 0.14p |
08:56 | 1,800,295 @ 0.14p |
08:56 | 1,184,553 @ 0.14p |
You are here: research